In August, Senses Cultural participated in a series of discussions to help finalize a research venture on autism and neurodevelopmental disorders in association with the UC Davis MIND Institute and with the collaboration of Dr. Alessandrop Prigione and the Heinrich Heine University (HHU) in Germany.
The research project is based on the science of editing DNA, through clustered repeated sequences known as Crisprs. To recognize the importance of the field, the 2020 Nobel Prize in Chemistry was awarded to two scientists, Dr. Jennifer Doudna and Dr. Emmanuelle Chapentier, for the cutting- edge work in Crisprs.
Our experts for this project bring in a wealth of experience to ensure its success. Drs. Randi and Paul Hagerman, specialists in neurodevelopmental disorders at UC Davis and the MIND Institute who first discovered the neurodegenerative disorder FXTAS in 2001, and Dr. Alessandrop Prigione, a specialist in mitochondria and cell fate reprogramming at HHU, bring a combined expertise in fragile X syndrome and associated disorders, and in investigating neurodevelopmental disorders.
Senses Cultural is proud to support this project. Next year, through our sponsorship, Dr. Prigione will be a speaker participant at the Stem Cell and Neurodevelopmental Disorders Conference at the MIND Institute. Senses Cultural is actively raising funds to support the conference, and a post-doctoral position to help Dr. Prigione’s contribution to this project, as well as a research position to support The Mind Institute. For information about our fundraising campaign for this project, please visit:
The preliminary data for this research will be released in a year, and form the basis of a larger grant. The research will particularly look into and find targeted treatments for the recessive conditions common among families of Middle Eastern descent, to help address the causes and treatments for autism and other neurodevelopmental disorders in this community.